ValiRx plc
VAL.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | – | £50 | £0 | £10 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | – | £133 | £134 | £137 |
| Gross Profit | – | -£83 | -£134 | -£128 |
| % Margin | – | -166.8% | – | -1,331.5% |
| R&D Expenses | – | £124 | £121 | £176 |
| G&A Expenses | – | £0 | £0 | £0 |
| SG&A Expenses | – | £877 | £832 | £844 |
| Sales & Mktg Exp. | – | £0 | £0 | £0 |
| Other Operating Expenses | – | £0 | £0 | £0 |
| Operating Expenses | – | £1,001 | £954 | £1,019 |
| Operating Income | – | -£1,084 | -£1,088 | -£1,147 |
| % Margin | – | -2,177% | – | -11,950.2% |
| Other Income/Exp. Net | – | £5 | £36 | -£3 |
| Pre-Tax Income | – | -£1,078 | -£1,052 | -£1,151 |
| Tax Expense | – | -£75 | -£52 | -£85 |
| Net Income | – | -£945 | -£971 | -£1,002 |
| % Margin | – | -1,898.1% | – | -10,440.4% |
| EPS | – | -0.007 | -0.007 | -0.01 |
| % Growth | – | 4.1% | 24.5% | – |
| EPS Diluted | – | -0.007 | -0.007 | -0.01 |
| Weighted Avg Shares Out | – | 132,376 | 131,194 | 102,320 |
| Weighted Avg Shares Out Dil | – | 132,376 | 131,194 | 102,320 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | £6 | £6 | £0 |
| Interest Expense | – | £1 | £0 | £3 |
| Depreciation & Amortization | – | £133 | £134 | £136 |
| EBITDA | – | -£915 | -£918 | -£1,011 |
| % Margin | – | -1,837.5% | – | -10,533.7% |